Global Nipah virus infection testing market is anticipated to grow at a CAGR of 4.8% during the forecast period (2023-2030). Nipah virus testing is primarily used for diagnostic purposes to detect genetic material or antibodies in patient samples. Different methods such as PCR, ELISA, and rapid diagnostic tests can be used for this. Regular testing is conducted to monitor the presence of the Nipah virus in specific areas and among certain populations. When Nipah virus cases are confirmed, contact tracing is done to identify and test individuals who may have been exposed to the virus. Testing is also an important part of investigating Nipah virus outbreaks as it helps to identify the source of infection, trace transmission chains, and confirm new cases.
Browse the full report description of “Nipah Virus Infection Testing Market Size, Share & Trends Analysis Report By Test (RT PCR Based Kits, and ELISA Kits), By Sample (Blood Serum or Plasma, Saliva and Throat Swabs, Urine, and Others), By End-User (Hospitals, Research Institutions, Diagnostic Centers, and Others), Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/nipah-virus-infection-testing-market
Furthermore, the market’s growth is attributed to rising concern for public health across the globe. Nipah virus is a potentially dangerous virus. Identifying cases of it quickly is essential to help prevent its spread. As such, improved diagnostic tools are necessary. For instance, in July 2022, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, launched a clinical trial of mRNA Nipah virus vaccine. It has been developed utilizing the identical messenger RNA (mRNA) platform as numerous authorized COVID-19 vaccines. The virus may rapidly progress from signs of a respiratory infection to encephalitis (brain swelling), which can result in a coma or death. According to estimates, between 40% and 75% of Nipah virus victims pass away. Even though animal-to-animal transmission accounts for the majority of cases, it is additionally possible. A licensed vaccine or remedy for Nipah virus infection is initially accessible.
Market Coverage
• The market number available for – 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Test Type
o By Sample
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Creative Biogene, Jiangsu Bioperfectus Technologies Co., Ltd., Molbio Diagnostics Pvt. Ltd., and YouSeq Ltd.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Nipah Virus Infection Testing Market Report Segment
By Test Type
By Sample
By End-User
Global Nipah Virus Infection Testing Market Report Segment by Region
North America
• United States
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/nipah-virus-infection-testing-market